Endogenous factors that physiologically enhance anti-tumor T cell activity through CD8 desialylation are not known, in part because defined sialidases are neither highly expressed, nor found frequently mutated, in tumors including GBM [14]. The gene discussed is CD8A; the disease is glioblastoma.